Can men with oligometastatic disease benefit from radiation treatment to the prostate? [Video]

🎯 The METANOVA trial explores whether adding MDRT to standard treatments can delay prostate cancer recurrence or extend patient survival.

Watch:
https://www.primrmed.com/cancer-clinical-trials/stampede2

#PRIMR boasts 100% IRB approval, reflecting top-notch quality and reliability.

PIs: Daniel E Spratt, Angela Jia

#cancer #oncology #prostatecancer #oligomets #oligometastatic #metastaticprostatecancer #hormonetherapy #systemictherapy #radiation #radiationtherapy #RT #MDRT #clinicalresearch #clinicaltrials #reels #shorts #shortsvideo #shortsfeed #shortstory #video #videoviral #learnontiktok #PRIMR